help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0620
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Alessio, A.
Right arrow Articles by de Franciscis, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Alessio, A.
Right arrow Articles by de Franciscis, V.
Endocrinology Vol. 144, No. 10 4298-4305
Copyright © 2003 by The Endocrine Society

The Tyrosine Phosphatase Shp-2 Mediates Intracellular Signaling Initiated by Ret Mutants

A. D’Alessio, D. Califano, M. Incoronato, G. Santelli, T. Florio, G. Schettini, M. S. Carlomagno, L. Cerchia and V. de Franciscis

Oncologia Sperimentale E, Istituto Nazionale Tumori (A.D’A., D.C., G.Sa.), Fondazione "G. Pascale," 80131 Naples, Italy; Dipartimento di Biologia e Patologia Cellulare e Molecolare (M.I., M.S.C.), Università di Napoli "Federico II," 80131 Naples, Italy; Farmacologia e Neuroscienze Istituto Nazionale per la Ricerca sul Cancro (T.F., G.Sc.), 16132 Genova, Italy; Sez Farmacologia, Dip. Oncologia (T.F., G.Sc.), Biologia e Genetica, Università di Genova, 16132 Genova, Italy; and Istituto di Endocrinologia ed Oncologia Sperimentale "G. Salvatore" del Consiglio Nazionale delle Ricerche (L.C., V.d.F.), 80131 Naples, Italy

Address all correspondence and requests for reprints to: V. de Franciscis, Istituto di Endocrinologia ed Oncologia Sperimentale "G. Salvatore" del Consiglio Nazionale delle Ricerche via S. Pansini 5, 80131 Naples, Italy.

The Src homology 2-containing tyrosine phosphatase, Shp-2, is a crucial enzyme that mediates intracellular signaling and is implicated in cell proliferation and differentiation. Here we investigated the involvement of the Shp-2 tyrosine phosphatase in determining the downstream signaling pathways initiated by the Ret oncogene, carrying either the cysteine 634 to tyrosine or the methionine 918 to threonine substitutions. These mutations convert the receptor tyrosine kinase, Ret, into a dominant transforming protein and induce constitutive activation of its intrinsic tyrosine kinase activity leading to congenital and sporadic cancers in neuroendocrine organs. Using the PC12, rat pheochromocytoma cell line, as model system, we show that Shp-2 mediates immediate-early gene expression if induced by either of the mutant alleles. Furthermore, we show that Shp-2 activity is required for RetM918T-induced Akt activation. The results indicate that Shp-2 is a downstream mediator of the mutated receptors RetC634Y and RetM918T, thus suggesting that it may act as a limiting factor in Ret-associated endocrine tumors, in the neoplastic syndromes multiple endocrine neoplasia types 2A and 2B.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
A. Cerrato, V. De Falco, and M. Santoro
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
J. Mol. Endocrinol., October 1, 2009; 43(4): 143 - 155.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Voena, C. Conte, C. Ambrogio, E. Boeri Erba, F. Boccalatte, S. Mohammed, O. N. Jensen, G. Palestro, G. Inghirami, and R. Chiarle
The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration
Cancer Res., May 1, 2007; 67(9): 4278 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio
An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta}
Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. C. Zatelli, D. Piccin, F. Tagliati, A. Bottoni, A. Luchin, and E. C. degli Uberti
Src Homology-2-Containing Protein Tyrosine Phosphatase-1 Restrains Cell Proliferation in Human Medullary Thyroid Carcinoma
Endocrinology, June 1, 2005; 146(6): 2692 - 2698.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Z. Liu, J. Falola, X. Zhu, Y. Gu, L. T. Kim, G. A. Sarosi, T. Anthony, and F. E. Nwariaku
Antiproliferative Effects of Src Inhibition on Medullary Thyroid Cancer
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3503 - 3509.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society